Comparative sensitivity of urinary CYFRA 21-1, urinary bladder cancer antigen, tissue polypeptide antigen and NMP22*to detect bladder cancer - Comment

被引：0
|
作者：
Grossman, HB [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA
来源：
JOURNAL OF UROLOGY | 1999年 / 162卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1956 / 1956
页数：1
相关论文
共 50 条
  • [1] Comparative sensitivity of urinary CYFRA 21-1, urinary bladder cancer antigen, tissue polypeptide antigen and NMP22*to detect bladder cancer
    Sánchez-Carbayo, M
    Herrero, E
    Megías, J
    Mira, A
    Soria, F
    JOURNAL OF UROLOGY, 1999, 162 (06): : 1951 - 1956
  • [2] Comparative predictive values of urinary cytology, urinary bladder cancer antigen, CYFRA 21-1 and NMP22 for evaluating symptomatic patients at risk for bladder cancer - Comment
    Droller, MJ
    JOURNAL OF UROLOGY, 2001, 165 (05): : 1466 - 1467
  • [3] Comparative predictive values of urinary cytology, urinary bladder cancer antigen, CYFRA 21-1 and NMP22 for evaluating symptomatic patients at risk for bladder cancer
    Sánchez-Carbayo, M
    Urrutia, M
    Silva, JM
    Romaní, R
    De Buitrago, JMG
    Navajo, JA
    JOURNAL OF UROLOGY, 2001, 165 (05): : 1462 - 1466
  • [4] Comparative predictive values of urinary cytology, urinary bladder cancer antigen, CYFRA 21-1 and NMP22 for evaluating symptomatic patients at risk for bladder cancer - Reply
    不详
    JOURNAL OF UROLOGY, 2001, 165 (05): : 1467 - 1467
  • [5] Comparative role of urinary NMP22, CYFRA 21-1, quantitative and qualitative UBC and TPA in the diagnosis of bladder cancer.
    Sánchez-Carbayo, M
    Herrero, E
    Megías, J
    Mira, A
    Molina, R
    Soria, F
    CLINICAL CHEMISTRY, 1999, 45 (06) : A116 - A117
  • [6] Comparative evaluation of the diagnostic performance of the BTA stat test, NMP22 and urinary bladder cancer antigen for primary and recurrent bladder tumors
    Giannopoulos, A
    Manousakas, T
    Gounari, A
    Constantinides, C
    Choremi-Papadopoulou, H
    Dimopoulos, C
    JOURNAL OF UROLOGY, 2001, 166 (02): : 470 - 475
  • [7] Urinary NMP22® BladderChek® test in the diagnosis of superficial bladder cancer
    Moonen, PMJ
    Kiemeney, LALM
    Witjes, JA
    EUROPEAN UROLOGY, 2005, 48 (06) : 951 - 956
  • [8] Urinary tissue polypeptide-specific antigen for the diagnosis of bladder cancer
    Sánchez-Carbayo, M
    Urrutia, M
    Silva, JM
    Romaní, R
    García, J
    Alférez, F
    de Buitrago, JMG
    Navajo, JA
    UROLOGY, 2000, 55 (04) : 526 - 532
  • [9] Usefulness of urinary NMP22 to detect tumor recurrence of superficial bladder cancer after transurethral resection
    Naoto Miyanaga
    Hideyuki Akaza
    Sadamu Tsukamoto
    Toru Shimazui
    Mikinobu Ohtani
    Satoru Ishikawa
    Ryosuke Noguchi
    Fumio Manabe
    Yukiko Nishijima
    Koji Kikuchi
    Ken Sato
    Hitoshi Hayashi
    Fukuji Kondo
    Hiroshi Shiraiwa
    Osamu Aoyama
    International Journal of Clinical Oncology, 2003, 8 (6) : 369 - 373
  • [10] Diagnostic values of urine CYFRA21-1, NMP22, UBC, and FDP for the detection of bladder cancer
    Jeong, Seri
    Park, Yongjung
    Cho, Yonggeun
    Kim, Young Ran
    Kim, Hyon-Suk
    CLINICA CHIMICA ACTA, 2012, 414 : 93 - 100
12345